DD141520A5 - Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden - Google Patents

Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden Download PDF

Info

Publication number
DD141520A5
DD141520A5 DD79210583A DD21058379A DD141520A5 DD 141520 A5 DD141520 A5 DD 141520A5 DD 79210583 A DD79210583 A DD 79210583A DD 21058379 A DD21058379 A DD 21058379A DD 141520 A5 DD141520 A5 DD 141520A5
Authority
DD
German Democratic Republic
Prior art keywords
amino
methoxy
acid
ethyl
formula
Prior art date
Application number
DD79210583A
Other languages
German (de)
English (en)
Inventor
Michel Thominet
Jacques Acher
Jean-Claude Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DD141520A5 publication Critical patent/DD141520A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
DD79210583A 1978-01-20 1979-01-22 Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden DD141520A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
DD141520A5 true DD141520A5 (de) 1980-05-07

Family

ID=9203689

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79210583A DD141520A5 (de) 1978-01-20 1979-01-22 Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden

Country Status (42)

Country Link
US (2) US4294828A (US06312121-20011106-C00033.png)
JP (1) JPS6049192B2 (US06312121-20011106-C00033.png)
AR (2) AR221354A1 (US06312121-20011106-C00033.png)
AT (1) AT377977B (US06312121-20011106-C00033.png)
AU (1) AU528561B2 (US06312121-20011106-C00033.png)
BE (1) BE872585A (US06312121-20011106-C00033.png)
BG (2) BG31496A3 (US06312121-20011106-C00033.png)
CA (1) CA1101430A (US06312121-20011106-C00033.png)
CH (1) CH637927A5 (US06312121-20011106-C00033.png)
CS (1) CS226181B2 (US06312121-20011106-C00033.png)
CY (1) CY1201A (US06312121-20011106-C00033.png)
DD (1) DD141520A5 (US06312121-20011106-C00033.png)
DE (1) DE2901181C2 (US06312121-20011106-C00033.png)
DK (1) DK158346C (US06312121-20011106-C00033.png)
EG (1) EG14045A (US06312121-20011106-C00033.png)
ES (2) ES476755A1 (US06312121-20011106-C00033.png)
FI (1) FI71126C (US06312121-20011106-C00033.png)
FR (1) FR2415099A1 (US06312121-20011106-C00033.png)
GB (2) GB2012765B (US06312121-20011106-C00033.png)
GR (1) GR64431B (US06312121-20011106-C00033.png)
HK (1) HK12184A (US06312121-20011106-C00033.png)
HU (1) HU179793B (US06312121-20011106-C00033.png)
IE (1) IE47798B1 (US06312121-20011106-C00033.png)
IL (1) IL56411A (US06312121-20011106-C00033.png)
IN (1) IN150226B (US06312121-20011106-C00033.png)
IT (1) IT1164655B (US06312121-20011106-C00033.png)
LU (1) LU80786A1 (US06312121-20011106-C00033.png)
MC (1) MC1232A1 (US06312121-20011106-C00033.png)
MX (2) MX7623E (US06312121-20011106-C00033.png)
NL (1) NL191707C (US06312121-20011106-C00033.png)
NO (1) NO151320C (US06312121-20011106-C00033.png)
NZ (1) NZ189378A (US06312121-20011106-C00033.png)
OA (1) OA06156A (US06312121-20011106-C00033.png)
PH (2) PH15725A (US06312121-20011106-C00033.png)
PL (2) PL116532B1 (US06312121-20011106-C00033.png)
PT (1) PT69068A (US06312121-20011106-C00033.png)
RO (2) RO76393A (US06312121-20011106-C00033.png)
SE (2) SE448874B (US06312121-20011106-C00033.png)
SU (1) SU820659A3 (US06312121-20011106-C00033.png)
YU (2) YU42172B (US06312121-20011106-C00033.png)
ZA (1) ZA79219B (US06312121-20011106-C00033.png)
ZM (1) ZM579A1 (US06312121-20011106-C00033.png)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
WO2004100992A2 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
EP1753460A2 (en) * 2004-05-11 2007-02-21 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
PE20061318A1 (es) * 2005-04-22 2006-12-28 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
EP2321011A1 (en) * 2008-06-25 2011-05-18 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
CA2969926C (en) 2009-02-20 2018-05-15 2-Bbb Medicines B.V. Glutathione-based drug delivery system
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
WO2011158084A1 (en) 2010-06-17 2011-12-22 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US10259786B2 (en) * 2016-11-28 2019-04-16 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
CN112118838A (zh) 2017-12-05 2020-12-22 赛诺维信制药公司 非外消旋混合物及其用途
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
KR20220018004A (ko) 2019-06-04 2022-02-14 선오비온 파마슈티컬스 인코포레이티드 조절 방출 제형 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (US06312121-20011106-C00033.png) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
CA1039731A (en) * 1974-12-18 1978-10-03 Synthelabo Process for preparing new 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
DE2901181C2 (de) 1984-07-19
MX5793E (es) 1984-07-19
ZA79219B (en) 1980-01-30
SE460968B (sv) 1989-12-11
IL56411A0 (en) 1979-03-12
ATA39879A (de) 1983-12-15
NL191707B (nl) 1995-12-01
CS226181B2 (en) 1984-03-19
HK12184A (en) 1984-02-24
MC1232A1 (fr) 1979-10-26
OA06156A (fr) 1981-06-30
IE47798B1 (en) 1984-06-27
JPS6049192B2 (ja) 1985-10-31
YU5079A (en) 1983-06-30
YU25483A (en) 1983-10-31
SU820659A3 (ru) 1981-04-07
IT1164655B (it) 1987-04-15
NL191707C (nl) 1996-04-02
AT377977B (de) 1985-05-28
GR64431B (en) 1980-03-21
RO80311A (ro) 1982-12-06
DE2901181A1 (de) 1979-07-26
EG14045A (en) 1983-09-30
FR2415099A1 (fr) 1979-08-17
PH22287A (en) 1988-07-22
US4294828A (en) 1981-10-13
BE872585A (fr) 1979-06-07
FI71126C (fi) 1986-11-24
PL212899A1 (US06312121-20011106-C00033.png) 1980-01-14
AU4337379A (en) 1979-07-26
DK158346B (da) 1990-05-07
IT7947706A0 (it) 1979-01-18
PL118151B1 (en) 1981-09-30
NL7900457A (nl) 1979-07-24
SE448874B (sv) 1987-03-23
JPS54145658A (en) 1979-11-14
GB2083458A (en) 1982-03-24
NZ189378A (en) 1983-03-15
BG31496A3 (en) 1982-01-15
MX7623E (es) 1990-03-27
DK158346C (da) 1990-10-08
FR2415099B1 (US06312121-20011106-C00033.png) 1981-02-20
CH637927A5 (fr) 1983-08-31
NO790180L (no) 1979-07-23
IL56411A (en) 1982-09-30
ES476755A1 (es) 1979-06-01
PH15725A (en) 1983-03-18
SE8603773L (sv) 1986-09-09
NO151320C (no) 1985-04-17
BG31497A3 (en) 1982-01-15
NO151320B (no) 1984-12-10
CY1201A (en) 1983-12-31
ZM579A1 (en) 1979-12-21
SE8603773D0 (sv) 1986-09-09
DK20979A (da) 1979-07-21
IE790092L (en) 1979-07-20
GB2012765A (en) 1979-08-01
HU179793B (en) 1982-12-28
US4401822A (en) 1983-08-30
GB2083458B (en) 1983-03-09
RO76393A (ro) 1981-03-30
IN150226B (US06312121-20011106-C00033.png) 1982-08-21
ES477782A1 (es) 1979-09-16
AU528561B2 (en) 1983-05-05
YU41278B (en) 1986-12-31
CA1101430A (en) 1981-05-19
FI71126B (fi) 1986-08-14
LU80786A1 (fr) 1979-09-07
SE7900380L (sv) 1979-07-21
PL116532B1 (en) 1981-06-30
PT69068A (fr) 1979-02-01
GB2012765B (en) 1982-09-08
FI790182A (fi) 1979-07-21
AR220574A1 (es) 1980-11-14
YU42172B (en) 1988-06-30
AR221354A1 (es) 1981-01-30

Similar Documents

Publication Publication Date Title
DD141520A5 (de) Verfahren zur herstellung neuer derivate von 4-amino-5-alkylsulfonyl-ortho-anisamiden
DE3026201C2 (US06312121-20011106-C00033.png)
CH635823A5 (de) Verfahren zur herstellung von neuen 1-amidin-3-substituierten-phenylharnstoffen.
DE2845496A1 (de) N hoch 2 -substituierte phenyl-2,6- diaminonebularine und sie enthaltende arzneimittelzubereitungen
EP0153277A2 (de) Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2847792C2 (US06312121-20011106-C00033.png)
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
DE2305092A1 (de) Alpha-aminomethylbenzylalkoholderivate
DD235256A5 (de) Verfahren zur herstellung neuer substituierter pyrrolidinone
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE3216843C2 (de) 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH380746A (de) Verfahren zur Herstellung neuer sekundärer Amine
DE2517020A1 (de) Alkanolaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2609862C2 (US06312121-20011106-C00033.png)
EP0007525A1 (de) 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
CH630895A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
DE2611118C2 (US06312121-20011106-C00033.png)
DD210909A5 (de) Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
DD253616A5 (de) Verfahren zur herstellung von neuen pleunromutilinderivaten
DE2403512C2 (de) 6-[D-2-Phenyl-2-(4-pyridoimidoylaminoacetamido) acetamido]-penicillansäure und deren pharmazeutisch verträgliche Salze sowie Verfahren zu deren Herstellung
DE2705949A1 (de) Neue therapeutika auf piperidinbasis
EP0138034A1 (de) Substituierte Pyrido(1,2-c)imidazo((1,2-a)benzimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3204074C2 (US06312121-20011106-C00033.png)
DE1670143C3 (US06312121-20011106-C00033.png)
DE2733194A1 (de) 2-eckige klammer auf 4-(p-aminobenzyl)-1-piperazinyl eckige klammer zu -8-aethyl-5,8-dihydro-5-oxopyrido-eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carbonsaeure, verfahren zu ihrer herstellung und diese verbindung enthaltendes arzneimittel